Site Editor

Rebecca Olin, MD, MS


Mikkael A. Sekeres, MD, on a Less Aggressive Alternative for Hematologic Malignancies

Posted: Sunday, March 1, 2020

Mikkael A. Sekeres, MD, of the Cleveland Clinic, talks about whether a “gentler” treatment of glasdegib plus azacitidine would be of benefit for patients with untreated acute myeloid leukemia.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.